Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...

In patients with advanced or recurrent endometrial cancer (EC) with previous exposure to carboplatin and paclitaxel (PT), ...

Byline: Umesh Isalkar Poonam was relieved when MRI and PET scans confirmed her endometrial cancer was in the early, ...

Moore, MD, discusses the exciting advancements in endometrial cancer treatment, particularly over the past 2 years, as she ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...

Combination treatment with cadonilimab and lenvatinib can produce responses in patients with advanced endometrial cancer.

Your outlook depends on how far your cancer has spread when you’re first diagnosed with it. To show the survival rates for endometrial cancer, the American Cancer Society uses a database that ...

Moderate daily exercise significantly reduced the risk of death from cardiovascular disease among female cancer survivors, a ...